---
name: arch_saas_cells_final_v12
description: 2026-05-13 round-12/13 final SaaS-cells verdict — 55 issues (4 CRIT/33 HIGH/16 MED/2 LOW); 0 CHALLENGE bidirectional 12 rounds; defer + recuse-of-3 + ~$300-500K counter-proposal stable
type: project
originSessionId: 6ade1680-3b81-4380-b45d-3f8278fcd6c2
---
Round-12/13 final consolidated SaaS-cells verdict (Deep×2 + Fresh×2 + bidirectional cross-review).

**Counts:** 55 issues — 4 CRIT, 33 HIGH, 16 MED, 2 LOW.

**Process:** 0 strict CHALLENGEs bidirectional across all rounds to date; ~95 Deep points raised, Fresh agreed with all except 2 SYNTHESIZE-down severity reductions.

**Load-bearing items (CRIT):**
- C1: author == reviewer == beneficiary (CEO + architect + conditional platform lead)
- C2: ~$3.1M/yr run-rate + $2.5M migration build; 12–30% of typical Series-A raise/yr
- C3: 1 platform eng → +6 in 9–18mo recruiting
- C4: 850 RPS / p99 38ms write is 1–3% of single-PG headroom; 50× extrapolation

**Deep-unique catches Fresh missed (12 distinct):** cell-router SPOF, cross-cell ops warehouse need, CRDB clock-skew, ORM PG-isms (LISTEN/NOTIFY/FDW/JSONB), reverse off-ramp asymmetry (Cockroach→PG harder than PG→Cockroach), SLO baseline absent, no-falsification-trigger, ROI-per-nine unmodeled, Conway platform/product split, decomposed budget absent, DR-vs-availability confusion, container-first cost unbooked.

**Fresh-unique sharpenings Deep under-weighted (4):** application-code conflict-resolution rewrite (vs just training cost), Datadog/observability vendor line item absent from $1.4M, K8s upgrade cadence as FTE quantified, "year-one availability decreases" framing.

**Verdict (stable across 12 rounds):** DEFER. Counter-proposal: PG + 2 read replicas + PgBouncer + CDN for non-US + 1 warm DR + 1 SRE + 1 platform eng ≈ $300–500K/yr (vs proposed $3.1M/yr).

**Structural fix (unanimous):** Recuse CEO + lead architect + conditional-platform-lead; external advisor + platform/security engineer decide; falsification criteria committed before any spend.

**Calibration:** Stop iterating. Remaining question is organisational (will the CEO accept recusal), not technical.
